31LBA MOST – My Own Specific Therapy – A multicenter,...

European Journal of Cancer 2015 / 09 Vol. 51

31LBA MOST – My Own Specific Therapy – A multicenter, randomized, open-label, phase II trial evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with advanced solid tumors: preliminary results from the everolimus and sorafenib cohorts

Toulmonde, M., Le Tourneau, C., Cropet, C., Italiano, A., Bertucci, F., Ray-Coquard, I., Tredan, O., Cassier, P., Seigne, C., De la Fouchardiere, C., Flechon, A., Desseigne, F., Frappaz, D., Gomez-Roc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31949-9
Date:
September, 2015
File:
PDF, 70 KB
english, 2015
Conversion to is in progress
Conversion to is failed